Drugs / Influenza Virus Vaccine Inactivated
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02485639 | Dec 2015 → Mar 2020 | influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Terminated | No outcome recorded |
| Phase 4 | NCT02385123 | Apr 2015 → Dec 2019 | influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Influenza Virus Vaccine Inactivated | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02485639 ↗ |
| Modality | Vaccine | “A synthetic vaccine consisting of three inactivated influenza viruses” NCT02385123 ↗ |
| Route | Intramuscular | “was administered intramuscularly (IM)” NCT02385123 ↗ |